title: Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives: reply to a rebuttal.
authors.forename: M
authors.initials: M
authors.lastname: Raps
authors.forename: F M
authors.initials: FM
authors.lastname: Helmerhorst
authors.forename: K
authors.initials: K
authors.lastname: Fleischer
authors.forename: A
authors.initials: A
authors.lastname: van Hylckama Vlieg
authors.forename: V A
authors.initials: VA
authors.lastname: Van Hylckama
authors.forename: B H
authors.initials: BH
authors.lastname: Stegeman
authors.forename: S
authors.initials: S
authors.lastname: Thomassen
authors.forename: F R
authors.initials: FR
authors.lastname: Rosendaal
authors.forename: J
authors.initials: J
authors.lastname: Rosing
authors.forename: B E P B
authors.initials: BE
authors.lastname: Ballieux
authors.forename: H A A M
authors.initials: HA
authors.lastname: Van Vliet
mesh_terms: D001777:Blood Coagulation / Q000187:drug effects*; D003271:Contraceptive Agents, Female / Q000009:adverse effects*; D005260:Female; D006801:Humans; D012738:Sex Hormone-Binding Globulin / Q000378:metabolism*; D020246:Venous Thrombosis / Q000139:chemically induced*
chemical_list: D003271:Contraceptive Agents, Female; D012738:Sex Hormone-Binding Globulin